Effects of the isoprostane, 8-epi-prostaglandin F2α, on the contractility of the human myometrium in vitro
- 16 October 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 285 (2), 151-158
- https://doi.org/10.1016/0014-2999(95)00398-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of some naturally occurring prostanoids and some cyclooxygenase inhibitors on the contractility of the human lower uterine segment in vitroCanadian Journal of Physiology and Pharmacology, 1994
- Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Inhibition of contractions of the isolated human myometrium by potassium channel openersAmerican Journal of Obstetrics and Gynecology, 1993
- The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonistProstaglandins, 1992
- In vitro characterization of prostanoid EP‐receptors in the non‐pregnant human myometriumBritish Journal of Pharmacology, 1991
- Acta Commentary: Modern Treatment of DysmenorrheaActa Obstetricia et Gynecologica Scandinavica, 1990
- The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonistCanadian Journal of Physiology and Pharmacology, 1989
- GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitroBritish Journal of Pharmacology, 1989
- The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonistBritish Journal of Pharmacology, 1989
- Preparation and stability of indomethacin solutionsCanadian Journal of Physiology and Pharmacology, 1982